Association between Helicobacter spp. infections and hepatobiliary malignancies: A review

World Journal of Gastroenterology

Volumn 21, Issue 5, 2015, Pages 1414-1423

  Segura López, Fany Karina ^a   Güitrón Cantú, Alfredo ^a   Torres, Javier ^b  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b HOSPITAL DE PEDIATRÍA   (Mexico)

Author keywords

Biliary tract cancer; Cholangiocarcinoma; Extrahepatic cholangiocarcinoma; Helicobacter bilis; Helicobacter hepaticus; Helicobacter species

Indexed keywords

ARTICLE; BILE DUCT CARCINOMA; BILIARY TRACT DISEASE; CARCINOGENESIS; CHRONIC INFLAMMATION; DISEASE ASSOCIATION; HELICOBACTER BILIS; HELICOBACTER HEPATICUS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HEPATOBILIARY SYSTEM CANCER; HUMAN; NONHUMAN; STOMACH CANCER; TUMOR PROMOTION; ANIMAL; BILIARY TRACT NEOPLASMS; CELL TRANSFORMATION; CLASSIFICATION; HELICOBACTER; HELICOBACTER INFECTIONS; HOST PATHOGEN INTERACTION; LIVER NEOPLASMS; MICROBIOLOGY; PATHOGENICITY; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR;

ANIMALS; BILIARY TRACT NEOPLASMS; CELL TRANSFORMATION, NEOPLASTIC; HELICOBACTER; HELICOBACTER INFECTIONS; HOST-PATHOGEN INTERACTIONS; HUMANS; LIVER NEOPLASMS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS;

EID: 84922519617     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v21.i5.1414     Document Type: Article

References (107)

1. Guitron-Cantu A. Endoscopic treatment in malignant obstructive jaundice: In Endoscopic procedures in Gastroenterology. In: Cordova VJA, De la Torre BA, editors. 2nd ed. Endoscopic Procedures in Gastroenterology. Mexico: Ed Panamericana, 2009: 489-504
2. Shaib Y, El-Serag HB. The epidemiology of cholangiocarcinoma. Semin Liver Dis 2004; 24: 115-125 [PMID: 15192785 DOI: 10.1055/s-2004-828889]
3. Patel T. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology 2001; 33: 1353-1357 [PMID: 11391522 DOI: 10.1053/jhep.2001.25087]
4. Shaib YH, Davila JA, McGlynn K, El-Serag HB. Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? J Hepatol 2004; 40: 472-477 [PMID: 15123362 DOI: 10.1016/j.jhep.2003.11.030]
5. International Agency For Research On Cancer. 2012. Available from: URL: http://globocan.IARC.fr
6. Murakami K, Takahashi R, Ono M, Watanabe K, Okimoto T, Kodama M, Abe D, Kimura M, Fujioka T. Serodiagnosis of Helicobacter hepaticus infection in patients with liver and gastrointestinal diseases: western blot analysis and ELISA using a highly specific monoclonal antibody for H. hepaticus antigen. J Gastroenterol 2011; 46: 1120-1126 [PMID: 21656014 DOI: 10.1007/S00534-011-0414-x]
7. Andia ME, Hsing AW, Andreotti G, Ferreccio C. Geographic variation of gallbladder cancer mortality and risk factors in Chile: a population-based ecologic study. Int J Cancer 2008; 123: 1411-1416 [PMID: 18566990 DOI: 10.1002/IJC.23662]
8. Jongsuksuntigul P, Imsomboon T. Opisthorchiasis control in Thailand. Acta Trop 2003; 88: 229-232 [PMID: 14611877 DOI: 10.1016/j.actatropica.2003.01.002]
9. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; 1: 1311-1315 [PMID: 6145023 DOI: 10.1016/S0140-6736(84)91816-6]
10. Hattori T, Sugihara H. The pathological sequence in the development of gastric cancer: I. Scand J Gastroenterol Suppl 1996; 214: 34-35; discussion 40-43 [PMID: 8722404]
11. Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994. IARC Monogr Eval Carcinog Risks Hum 1994; 61: 1-241 [PMID: 7715068]
12. Ward JM, Anver DC, Haines LM. Chronic active hepatitis of unknown origin in mice from a large research facility. Vet Pathol 1993; 30: A4769
13. Fox JG. The non-H pylori helicobacters: their expanding role in gastrointestinal and systemic diseases. Gut 2002; 50: 273-283 [PMID: 11788573 DOI: 10.1136/gut.50.2.273]
14. Rossi M, Hänninen ML. Helicobacter spp. other than H. pylori. Helicobacter 2012; 17 Suppl 1: 56-61 [PMID: 22958157 DOI: 10.1111/J.1523-5378.2010.00984.x]
15. Holzinger F, Z'graggen K, Büchler MW. Mechanisms of biliary carcinogenesis: a pathogenetic multi-stage cascade towards cholangiocarcinoma. Ann Oncol 1999; 10 Suppl 4: 122-126 [PMID: 10436802]
16. Gores GJ. Cholangiocarcinoma: current concepts and insights. Hepatology 2003; 37: 961-969 [PMID: 12717374 DOI: 10.1053/jhep.2003.50200]
17. Meza-Junco J, Montano-Loza AJ, Ma M, Wong W, Sawyer MB, Bain VG. Cholangiocarcinoma: has there been any progress? Can J Gastroenterol 2010; 24: 52-57 [PMID: 20186357]
18. Ojima H, Kanai Y, Iwasaki M, Hiraoka N, Shimada K, Sano T, Sakamoto Y, Esaki M, Kosuge T, Sakamoto M, Hirohashi S. Intraductal carcinoma component as a favorable prognostic factor in biliary tract carcinoma. Cancer Sci 2009; 100: 62-70 [PMID: 19038006 DOI: 10.1111/j.1349-7006.2008.009.x]
19. Borghero Y, Crane CH, Szklaruk J, Oyarzo M, Curley S, Pisters PW, Evans D, Abdalla EK, Thomas MB, Das P, Wistuba II, Krishnan S, Vauthey JN. Extrahepatic bile duct adenocarcinoma: patients at high-risk for local recurrence treated with surgery and adjuvant chemoradiation have an equivalent overall survival to patients with standard-risk treated with surgery alone. Ann Surg Oncol 2008; 15: 3147-3156 [PMID: 18754070 DOI: 10.1245/s10434-008-9998-7]
20. Lim KH, Oh DY, Chie EK, Jang JY, Im SA, Kim TY, Kim SW, Ha SW, Bang YJ. Adjuvant concurrent chemoradiation therapy (CCRT) alone versus CCRT followed by adjuvant chemotherapy: which is better in patients with radically resected extrahepatic biliary tract cancer?: a non-randomized, single center study. BMC Cancer 2009; 9: 345 [PMID: 19781103 DOI: 10.1186/1471-2407-9-345]
21. Zaydfudim VM, Clark CJ, Kendrick ML, Que FG, Reid-Lombardo KM, Donohue JH, Farnell MB, Nagorney DM. Correlation of staging systems to survival in patients with resected hilar cholangiocarcinoma. Am J Surg 2013; 206: 159-165 [PMID: 23746658 DOI: 10.1016/J.AMJSURG.2012.11020]
22. Nagahashi M, Shirai Y, Wakai T, Sakata J, Ajioka Y, Nomura T, Tsuchiya Y, Hatakeyama K. Depth of invasion determines the postresectional prognosis for patients with T1 extrahepatic cholangiocarcinoma. Cancer 2010; 116: 400-405 [PMID: 19950133 DOI: 10.1002/cncr.24766]
23. Shindoh J, Vauthey JN. Staging of biliary tract and primary liver tumors. Surg Oncol Clin N Am 2014; 23: 313-322 [PMID: 24560112 DOI: 10.1016/j.soc.2013.11.003]
24. Ebata T, Kosuge T, Hirano S, Unno M, Yamamoto M, Miyazaki M, Kokudo N, Miyagawa S, Takada T, Nagino M. Proposal to modify the International Union Against Cancer staging system for perihilar cholangiocarcinomas. Br J Surg 2014; 101: 79-88 [PMID: 24375300 DOI: 10.1002/bjs.9379]
25. Robles R, Sánchez-Bueno F, Ramírez P, Brusadin R, Parrilla P. Liver transplantation for hilar cholangiocarcinoma. World J Gastroenterol 2013; 19: 9209-9215 [PMID: 24409049 DOI: 10.3748/WJG.V19.I48.9209]
26. Isayama H, Nakai Y, Kogure H, Yamamoto N, Koike K. Biliary self-expandable metallic stent for unresectable malignant distal biliary obstruction: which is better: covered or uncovered? Dig Endosc 2013; 25 Suppl 2: 71-74 [PMID: 23617653 DOI: 10.1111/den.12078]
27. Güitrón-Cantú A, Adalid-Martínez R, Gutiérrez-Bermúdez JA. [Self-expandable metallic biliary endoprosthesis in malignant obstructive jaundice]. Rev Gastroenterol Mex 2005; 70: 247-252 [PMID: 17063779]
28. Roe IH, Kim JT, Lee HS, Lee JH. Detection of Helicobacter DNA in bile from bile duct diseases. J Korean Med Sci 1999; 14: 182-186 [PMID: 10331565 DOI: 10.3346/jkms.1999.14.2.182]
29. Abu Al-Soud W, Stenram U, Ljungh A, Tranberg KG, Nilsson HO, Wadström T. DNA of Helicobacter spp. and common gut bacteria in primary liver carcinoma. Dig Liver Dis 2008; 40: 126-131 [PMID: 18083084 DOI: 10.1016/j.dld.2007.09.011]
30. Fox JG, Dewhirst FE, Tully JG, Paster BJ, Yan L, Taylor NS, Collins MJ, Gorelick PL, Ward JM. Helicobacter hepaticus sp. nov., a microaerophilic bacterium isolated from livers and intestinal mucosal scrapings from mice. J Clin Microbiol 1994; 32: 1238-1245 [PMID: 8051250]
31. Fox JG, Lee A. The role of Helicobacter species in newly recognized gastrointestinal tract diseases of animals. Lab Anim Sci 1997; 47: 222-255 [PMID: 9241625]
32. Fox JG, Rogers AB, Whary MT, Taylor NS, Xu S, Feng Y, Keys S. Helicobacter bilis-associated hepatitis in outbred mice. Comp Med 2004; 54: 571-577 [PMID: 15575372]
33. Shomer NH, Dangler CA, Schrenzel MD, Fox JG. Helicobacter bilis-induced inflammatory bowel disease in scid mice with defined flora. Infect Immun 1997; 65: 4858-4864 [PMID: 9353076]
34. Casswall TH, Németh A, Nilsson I, Wadström T, Nilsson HO. Helicobacter species DNA in liver and gastric tissues in children and adolescents with chronic liver disease. Scand J Gastroenterol 2010; 45: 160-167 [PMID: 20095882 DOI: 10.3109/00365520903426915]
35. Kobayashi T, Harada K, Miwa K, Nakanuma Y. Helicobacter genus DNA fragments are commonly detectable in bile from patients with extrahepatic biliary diseases and associated with their pathogenesis. Dig Dis Sci 2005; 50: 862-867 [PMID: 15906758 DOI: 10.1007/s10620-005-2654-1]
36. Kosaka T, Tajima Y, Kuroki T, Mishima T, Adachi T, Tsuneoka N, Fukuda K, Kanematsu T. Helicobacter bilis colonization of the biliary system in patients with pancreaticobiliary maljunction. Br J Surg 2010; 97: 544-549 [PMID: 20155791 DOI: 10.1002/bjs6907]
37. Fukuda K, Kuroki T, Tajima Y, Tsuneoka N, Kitajima T, Matsuzaki S, Furui J, Kanematsu T. Comparative analysis of Helicobacter DNAs and biliary pathology in patients with and without hepatobiliary cancer. Carcinogenesis 2002; 23: 1927-1931 [PMID: 12419842 DOI: 10.1093/carcin/23.11.1927]
38. Fowsantear W, Argo E, Pattinson C, Cash P. Comparative proteomics of Helicobacter species: the discrimination of gastric and enterohepatic Helicobacter species. J Proteomics 2014; 97: 245-255 [PMID: 23899588 DOI: 10.1016/j.jprot.2013.07.016]
39. Young VB, Knox KA, Schauer DB. Cytolethal distending toxin sequence and activity in the enterohepatic pathogen Helicobacter hepaticus. Infect Immun 2000; 68: 184-191 [PMID: 10603386 DOI: 10.1128/IAI.68.1.184-191.2000]
40. Fox JG, Li X, Yan L, Cahill RJ, Hurley R, Lewis R, Murphy JC. Chronic proliferative hepatitis in A/JCr mice associated with persistent Helicobacter hepaticus infection: a model of helicobacter-induced carcinogenesis. Infect Immun 1996; 64: 1548-1558 [PMID: 8613359]
41. García A, Zeng Y, Muthupalani S, Ge Z, Potter A, Mobley MW, Boussahmain C, Feng Y, Wishnok JS, Fox JG. Helicobacter hepaticus - induced liver tumor promotion is associated with increased serum bile acid and a persistent microbial-induced immune response. Cancer Res 2011; 71: 2529-2540 [PMID: 21335546 DOI: 10.1158/0008-5472.CAN/10/1975]
42. Fox JG, Shen Z, Muthupalani S, Rogers AR, Kirchain SM, Dewhirst FE. Chronic hepatitis, hepatic dysplasia, fibrosis, and biliary hyperplasia in hamsters naturally infected with a novel Helicobacter classified in the H. bilis cluster. J Clin Microbiol 2009; 47: 3673-3681 [PMID: 19759229 DOI: 10.1128/JCM.00879-09]
43. Petnicki-Ocwieja T, Hrncir T, Liu YJ, Biswas A, Hudcovic T, Tlaskalova-Hogenova H, Kobayashi KS. Nod2 is required for the regulation of commensal microbiota in the intestine. Proc Natl Acad Sci USA 2009; 106: 15813-15818 [PMID: 19805227 DOI: 10.1073/pnas.0907722106]
44. Mandell L, Moran AP, Cocchiarella A, Houghton J, Taylor N, Fox JG, Wang TC, Kurt-Jones EA. Intact gram-negative Helicobacter pylori, Helicobacter felis, and Helicobacter hepaticus bacteria activate innate immunity via toll-like receptor 2 but not toll-like receptor 4. Infect Immun 2004; 72: 6446-6454 [PMID: 15501775 DOI: 10.1128/IAI.72.11.6446-6454.2004]
45. Rao VP, Poutahidis T, Ge Z, Nambiar PR, Boussahmain C, Wang YY, Horwitz BH, Fox JG, Erdman SE. Innate immune inflammatory response against enteric bacteria Helicobacter hepaticus induces mammary adenocarcinoma in mice. Cancer Res 2006; 66: 7395-7400 [PMID: 16885333 DOI: 10.1158/0008-5472.CAN-06-0558]
46. Rudi J, Rudy A, Maiwald M, Stremmel W. Helicobacter sp. are not detectable in bile from German patients with biliary disease. Gastroenterology 1999; 116: 1016-1017 [PMID: 10092334 DOI: 10.1016/S0016-5085(99)70096-X]
47. Rice JM. Helicobacter hepaticus, a recently recognized bacterial pathogen, associated with chronic hepatitis and hepatocellular neoplasia in laboratory mice. Emerg Infect Dis 1995; 1: 129-131 [PMID: 8903182 DOI: 10.3201/eid0104.950404]
48. Erdman SE, Poutahidis T, Tomczak M, Rogers AB, Cormier K, Plank B, Horwitz BH, Fox JG. CD4+ CD25+ regulatory T lymphocytes inhibit microbially induced colon cancer in Rag2-deficient mice. Am J Pathol 2003; 162: 691-702 [PMID: 12547727 DOI: 10.1016/S0002-9440(10)63863-1]
49. Rao VP, Poutahidis T, Fox JG, Erdman SE. Breast cancer: should gastrointestinal bacteria be on our radar screen? Cancer Res 2007; 67: 847-850 [PMID: 17283110 DOI: 10.1158/0008-5472.CAN-06-3468]
50. Veijola L, Nilsson I, Halme L, Al-Soud WA, Mäkinen J, Ljungh A, Rautelin H. Detection of Helicobacter species in chronic liver disease and chronic inflammatory bowel disease. Ann Med 2007; 39: 554-560 [PMID: 17852032 DOI: 10.1080/07853890701545714]
51. Chen W, Li D, Cannan RJ, Stubbs RS. Common presence of Helicobacter DNA in the gallbladder of patients with gallstone diseases and controls. Dig Liver Dis 2003; 35: 237-243 [PMID: 12801034 DOI: 10.1016/S1590-8658(03)00060-4]
52. Nilsson HO, Taneera J, Castedal M, Glatz E, Olsson R, Wadström T. Identification of Helicobacter pylori and other Helicobacter species by PCR, hybridization, and partial DNA sequencing in human liver samples from patients with primary sclerosing cholangitis or primary biliary cirrhosis. J Clin Microbiol 2000; 38: 1072-1076 [PMID: 10698999]
53. Zhou D, Wang JD, Weng MZ, Zhang Y, Wang XF, Gong W, Quan ZW. Infections of Helicobacter spp. in the biliary system are associated with biliary tract cancer: a meta-analysis. Eur J Gastroenterol Hepatol 2013; 25: 447-454 [PMID: 23470268 DOI: 10.1097/MEG.0b013e32835c0362]
54. Maurer KJ, Ihrig MM, Rogers AB, Ng V, Bouchard G, Leonard MR, Carey MC, Fox JG. Identification of cholelithogenic enterohepatic helicobacter species and their role in murine cholesterol gallstone formation. Gastroenterology 2005; 128: 1023-1033 [PMID: 15825083 DOI: 10.1053/j.gastro.2005.01.008]
55. Vorobjova T, Nilsson I, Terjajev S, Granholm M, Lyyra M, Porkka T, Prükk T, Salupere R, Maaroos HI, Wadström T, Uibo R. Serum antibodies to enterohepatic Helicobacter spp. in patients with chronic liver diseases and in a population with high prevalence of H. pylori infection. Dig Liver Dis 2006; 38: 171-176 [PMID: 16464652 DOI: 10.1016/j.dld.2005.12.008]
56. Suerbaum S, Josenhans C, Sterzenbach T, Drescher B, Brandt P, Bell M, Droge M, Fartmann B, Fischer HP, Ge Z, Horster A, Holland R, Klein K, Konig J, Macko L, Mendz GL, Nyakatura G, Schauer DB, Shen Z, Weber J, Frosch M, Fox JG. The complete genome sequence of the carcinogenic bacterium Helicobacter hepaticus. Proc Natl Acad Sci USA 2003; 100: 7901-7906 [PMID: 12810954 DOI: 10.1073/pnas.1332093100]
57. Chien CC, Taylor NS, Ge Z, Schauer DB, Young VB, Fox JG. Identification of cdtB homologues and cytolethal distending toxin activity in enterohepatic Helicobacter spp. J Med Microbiol 2000; 49: 525-534 [PMID: 10847206]
58. Alyamani EJ, Brandt P, Pena JA, Major AM, Fox JG, Suerbaum S, Versalovic J. Helicobacter hepaticus catalase shares surface-predicted epitopes with mammalian catalases. Microbiology 2007; 153: 1006-1016 [PMID: 17379710 DOI: 10.1099/mic.0.29184-0]
59. Sterzenbach T, Bartonickova L, Behrens W, Brenneke B, Schulze J, Kops F, Chin EY, Katzowitsch E, Schauer DB, Fox JG, Suerbaum S, Josenhans C. Role of the Helicobacter hepaticus flagellar sigma factor FliA in gene regulation and murine colonization. J Bacteriol 2008; 190: 6398-6408 [PMID: 18689480 DOI: 10.1128/JB.00626-08]
60. Ge Z, Feng Y, Whary MT, Nambiar PR, Xu S, Ng V, Taylor NS, Fox JG. Cytolethal distending toxin is essential for Helicobacter hepaticus colonization in outbred Swiss Webster mice. Infect Immun 2005; 73: 3559-3567 [PMID: 15908385 DOI: 10.1128/IAI.73.6.3559-3567.2005]
61. Smith JL, Bayles DO. The contribution of cytolethal distending toxin to bacterial pathogenesis. Crit Rev Microbiol 2006; 32: 227-248 [PMID: 17123907 DOI: 10.1080/10408410601023557]
62. Ge Z, Schauer DB, Fox JG. In vivo virulence properties of bacterial cytolethal-distending toxin. Cell Microbiol 2008; 10: 1599-1607 [PMID: 18489725 DOI: 10.1111/j.1462-5822.2008.01173.x]
63. Liyanage NP, Manthey KC, Dassanayake RP, Kuszynski CA, Oakley GG, Duhamel GE. Helicobacter hepaticus cytolethal distending toxin causes cell death in intestinal epithelial cells via mitochondrial apoptotic pathway. Helicobacter 2010; 15: 98-107 [PMID: 20402812 DOI: 10.1111/j.1523-5378.210.00749.x]
64. Belzer C, van Schendel BA, Kuipers EJ, Kusters JG, van Vliet AH. Iron-responsive repression of urease expression in Helicobacter hepaticus is mediated by the transcriptional regulator Fur. Infect Immun 2007; 75: 745-752 [PMID: 17101656 DOI: 10.1128/IAI.01163-06]
65. Williams CL, Preston T, Hossack M, Slater C, McColl KE. Helicobacter pylori utilises urea for amino acid synthesis. FEMS Immunol Med Microbiol 1996; 13: 87-94 [PMID: 8821403 DOI: 10.1111/j.1574-695X.1996.tb00220.x]
66. Ward JM, Fox JG, Anver MR, Haines DC, George CV, Collins MJ, Gorelick PL, Nagashima K, Gonda MA, Gilden RV. Chronic active hepatitis and associated liver tumors in mice caused by a persistent bacterial infection with a novel Helicobacter species. J Natl Cancer Inst 1994; 86: 1222-1227 [PMID: 8040890 DOI: 10.1093/jnci/86.16.1222]
67. Boutin SR, Shen Z, Rogers AB, Feng Y, Ge Z, Xu S, Sterzenbach T, Josenhans C, Schauer DB, Suerbaum S, Fox JG. Different Helicobacter hepaticus strains with variable genomic content induce various degrees of hepatitis. Infect Immun 2005; 73: 8449-8452 [PMID: 16299349 DOI: 10.1128/IAI.73.12.8449-8452.2005]
68. Hong Y, Wang G, Maier RJ. A Helicobacter hepaticus catalase mutant is hypersensitive to oxidative stress and suffers increased DNA damage. J Med Microbiol 2007; 56: 557-562 [PMID: 17374900 DOI: 10.1099/jmm.0.46891-0]
69. Kullberg MC, Ward JM, Gorelick PL, Caspar P, Hieny S, Cheever A, Jankovic D, Sher A. Helicobacter hepaticus triggers colitis in specific-pathogen-free interleukin-10 (IL-10)-deficient mice through an IL-12- and gamma interferon-dependent mechanism. Infect Immun 1998; 66: 5157-5166 [PMID: 9784517]
70. Whary MT, Morgan TJ, Dangler CA, Gaudes KJ, Taylor NS, Fox JG. Chronic active hepatitis induced by Helicobacter hepaticus in the A/JCr mouse is associated with a Th1 cell-mediated immune response. Infect Immun 1998; 66: 3142-3148 [PMID: 9632578]
71. Cahill RJ, Foltz CJ, Fox JG, Dangler CA, Powrie F, Schauer DB. Inflammatory bowel disease: an immunity-mediated condition triggered by bacterial infection with Helicobacter hepaticus. Infect Immun 1997; 65: 3126-3131 [PMID: 9234764]
72. Okoli AS, Raftery MJ, Mendz GL. Effects of human and porcine bile on the proteome of Helicobacter hepaticus. Proteome Sci 2012; 10: 27 [PMID: 22533459 DOI: 10.1186/1477-5956-10-27]
73. Fritz JH, Ferrero RL, Philpott DJ, Girardin SE. Nod-like proteins in immunity, inflammation and disease. Nat Immunol 2006; 7: 1250-1257 [PMID: 17110941 DOI: 10.1038/ni1412]
74. Kullberg MC, Rothfuchs AG, Jankovic D, Caspar P, Wynn TA, Gorelick PL, Cheever AW, Sher A. Helicobacter hepaticus-induced colitis in interleukin-10-deficient mice: cytokine requirements for the induction and maintenance of intestinal inflammation. Infect Immun 2001; 69: 4232-4241 [PMID: 11401959 DOI: 10.1128/IAI.69.7.4232-4241.2001]
75. Erdman SE, Poutahidis T. Cancer inflammation and regulatory T cells. Int J Cancer 2010; 127: 768-779 [PMID: 20518013 DOI: 10.1002/ijc.25430]
76. Erdman SE, Poutahidis T, Rogers AB, Tomszaki M, Horwitz B, Fox JG. Susceptibility of three strains of Rag2-deficient mice to Helicobacter hepaticus induced colitis and colorectal cancer. Gastroenterology 2003; 124 Suppl 1: A340 [DOI: 10.1016/S0016-5085(03)81715-8]
77. Erdman SE, Rao VP, Poutahidis T, Rogers AB, Taylor CL, Jackson EA, Ge Z, Lee CW, Schauer DB, Wogan GN, Tannenbaum SR, Fox JG. Nitric oxide and TNF-alpha trigger colonic inflammation and carcinogenesis in Helicobacter hepaticusinfected, Rag2-deficient mice. Proc Natl Acad Sci USA 2009; 106: 1027-1032 [PMID: 19164562 DOI: 10.1073/pnas.0812347106]
78. Poutahidis T, Haigis KM, Rao VP, Nambiar PR, Taylor CL, Ge Z, Watanabe K, Davidson A, Horwitz BH, Fox JG, Erdman SE. Rapid reversal of interleukin-6-dependent epithelial invasion in a mouse model of microbially induced colon carcinoma. Carcinogenesis 2007; 28: 2614-2623 [PMID: 17724375 DOI: 10.1093/carcin/bgm180]
79. Sipowicz MA, Chomarat P, Diwan BA, Anver MA, Awasthi YC, Ward JM, Rice JM, Kasprzak KS, Wild CP, Anderson LM. Increased oxidative DNA damage and hepatocyte overexpression of specific cytochrome P450 isoforms in hepatitis of mice infected with Helicobacter hepaticus. Am J Pathol 1997; 151: 933-941 [PMID: 9327726]
80. Rao VP, Poutahidis T, Ge Z, Nambiar PR, Horwitz BH, Fox JG, Erdman SE. Proinflammatory CD4+ CD45RB(hi) lymphocytes promote mammary and intestinal carcinogenesis in Apc(Min/+) mice. Cancer Res 2006; 66: 57-61 [PMID: 16397216 DOI: 10.1158/0008-5472.CAN-05-3445]
81. Erdman SE, Rao VP, Olipitz W, Taylor CL, Jackson EA, Levkovich T, Lee CW, Horwitz BH, Fox JG, Ge Z, Poutahidis T. Unifying roles for regulatory T cells and inflammation in cancer. Int J Cancer 2010; 126: 1651-1665 [PMID: 19795459 DOI: 10.1002/ijc.24923]
82. Taniguchi T, Sekiya A, Higa M, Saeki Y, Umeki K, Okayama A, Hayashi T, Misawa N. Rapid identification and subtyping of Helicobacter cinaedi strains by intact-cell mass spectrometry profiling with the use of matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol 2014; 52: 95-102 [PMID: 24153128 DOI: 10.1128/JCM.01798-13]
83. Takayama S, Takahashi H, Matsuo Y, Okada Y, Takeyama H. Effect of Helicobacter bilis infection on human bile duct cancer cells. Dig Dis Sci 2010; 55: 1905-1910 [PMID: 19731027 DOI: 10.1007/s10620-009-0946-6]
84. Fox JG. Helicobacter bilis: bacterial provocateur orchestrates host immune responses to commensal flora in a model of inflammatory bowel disease. Gut 2007; 56: 898-900 [PMID: 17566023 DOI: 10.1136/gut.2006.115428]
85. Jergens AE, Wilson-Welder JH, Dorn A, Henderson A, Liu Z, Evans RB, Hostetter J, Wannemuehler MJ. Helicobacter bilis triggers persistent immune reactivity to antigens derived from the commensal bacteria in gnotobiotic C3H/HeN mice. Gut 2007; 56: 934-940 [PMID: 17145736 DOI: 10.1136/gut.2006.099242]
86. Liu Z, Ramer-Tait AE, Henderson AL, Demirkale CY, Nettleton D, Wang C, Hostetter JM, Jergens AE, Wannemuehler MJ. Helicobacter bilis colonization enhances susceptibility to Typhlocolitis following an inflammatory trigger. Dig Dis Sci 2011; 56: 2838-2848 [PMID: 21503679 DOI: 10.1007/s10620-011-1701-3]
87. Murata H, Tsuji S, Tsujii M, Fu HY, Tanimura H, Tsujimoto M, Matsuura N, Kawano S, Hori M. Helicobacter bilis infection in biliary tract cancer. Aliment Pharmacol Ther 2004; 20 Suppl 1: 90-94 [PMID: 15298612 DOI: 10.1111/j.1365-2036.2004.01972.x]
88. Matsukura N, Yokomuro S, Yamada S, Tajiri T, Sundo T, Hadama T, Kamiya S, Naito Z, Fox JG. Association between Helicobacter bilis in bile and biliary tract malignancies: H. bilis in bile from Japanese and Thai patients with benign and malignant diseases in the biliary tract. Jpn J Cancer Res 2002; 93: 842-847 [PMID: 12149151 DOI: 10.1111/j.1349-7006.2002.tb01327.x]
89. Romero S, Archer JR, Hamacher ME, Bologna SM, Schell RF. Case report of an unclassified microaerophilic bacterium associated with gastroenteritis. J Clin Microbiol 1988; 26: 142-143 [PMID: 3343307]
90. Murray PR, Jain A, Uzel G, Ranken R, Ivy C, Blyn LB, Ecker DJ, Sampath R, Lee CC, Turner ML. Pyoderma gangrenosum-like ulcer in a patient with X-linked agammaglobulinemia: identification of Helicobacter bilis by mass spectrometry analysis. Arch Dermatol 2010; 146: 523-526 [PMID: 20479300 DOI: 10.1001/archdermatol.2010.86]
91. Fox JG, Dewhirst FE, Shen Z, Feng Y, Taylor NS, Paster BJ, Ericson RL, Lau CN, Correa P, Araya JC, Roa I. Hepatic Helicobacter species identified in bile and gallbladder tissue from Chileans with chronic cholecystitis. Gastroenterology 1998; 114: 7055-763 [PMID: 9516396 DOI: 10.1016/S0016-5085(98)70589-X]
92. Pellicano R, Mazzaferro V, Grigioni WF, Cutufia MA, Fagoonee S, Silengo L, Rizzetto M, Ponzetto A. Helicobacter species sequences in liver samples from patients with and without hepatocellular carcinoma. World J Gastroenterol 2004; 10: 598-601 [PMID: 14966925]
93. Silva CP, Pereira-Lima JC, Oliveira AG, Guerra JB, Marques DL, Sarmanho L, Cabral MM, Queiroz DM. Association of the presence of Helicobacter in gallbladder tissue with cholelithiasis and cholecystitis. J Clin Microbiol 2003; 41: 5615-5618 [PMID: 14662950 DOI: 10.1128/JCM.41.12.5615-5618.2003]
94. Fox JG. Other helicobacters involved in human diseases. Acta Gastroenterol Belg 2002; 65: 24-32 [PMID: 12014313]
95. Maurer KJ, Rao VP, Ge Z, Rogers AB, Oura TJ, Carey MC, Fox JG. T-cell function is critical for murine cholesterol gallstone formation. Gastroenterology 2007; 133: 1304-1315 [PMID: 17919501 DOI: 10.1053/j.gastro.2007.07.005]
96. Pandey M, Shukla M. Helicobacter species are associated with possible increase in risk of hepatobiliary tract cancers. Surg Oncol 2009; 18: 51-56 [PMID: 18715780 DOI: 10.1016/j.suronc.2008.07.002]
97. Tak PP, Firestein GS. NF-kappaB: a key role in inflammatory diseases. J Clin Invest 2001; 107: 7-11 [PMID: 11134171 DOI: 10.1172/JCI11830]
98. Fox JG, Ge Z, Whary MT, Erdman SE, Horwitz BH. Helicobacter hepaticus infection in mice: models for understanding lower bowel inflammation and cancer. Mucosal Immunol 2011; 4: 22-30 [PMID: 20944559 DOI: 10.1038/mi.2010.61]
99. Zhou D, Zhang Y, Gong W, Mohamed SO, Ogbomo H, Wang X, Liu Y, Quan Z. Are Helicobacter pylori and other Helicobacter species infection associated with human biliary lithiasis? A meta-analysis. PLoS One 2011; 6: e27390 [PMID: 22087306]
100. Randi G, Franceschi S, La Vecchia C. Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer 2006; 118: 1591-1602 [PMID: 16397865 DOI: 10.1002/ijc.21683]
101. Pandey M. Helicobacter species are associated with possible increase in risk of biliary lithiasis and benign biliary diseases. World J Surg Oncol 2007; 5: 94 [PMID: 17708763 DOI: 10.1186/1477-7819-5-94]
102. Rossi M, Bolz C, Revez J, Javed S, El-Najjar N, Anderl F, Hyytiäinen H, Vuorela P, Gerhard M, Hänninen ML. Evidence for conserved function of γ-glutamyltranspeptidase in Helicobacter genus. PLoS One 2012; 7: e30543 [PMID: 22348013 DOI: 10.1371/journal.pone]
103. Javed S, Mejías-Luque R, Kalali B, Bolz C, Gerhard M. Helicobacter bilis gamma-glutamyltranspeptidase enhances inflammatory stress response via oxidative stress in colon epithelial cells. PLoS One 2013; 8: e73160 [PMID: 24009737 DOI: 10.1371/journal.pone.0073160]
104. Peek RM, Crabtree JE. Helicobacter infection and gastric neoplasia. J Pathol 2006; 208: 233-248 [PMID: 16362989 DOI: 10.1002/path.1868]
105. Myung SJ, Kim MH, Shim KN, Kim YS, Kim EO, Kim HJ, Park ET, Yoo KS, Lim BC, Seo DW, Lee SK, Min YI, Kim JY. Detection of Helicobacter pylori DNA in human biliary tree and its association with hepatolithiasis. Dig Dis Sci 2000; 45: 1405-1412 [PMID: 10961722 DOI: 10.1023/A:1005572507572]
106. Ananieva O, Nilsson I, Vorobjova T, Uibo R, Wadström T. Immune responses to bile-tolerant helicobacter species in patients with chronic liver diseases, a randomized population group, and healthy blood donors. Clin Diagn Lab Immunol 2002; 9: 1160-1164 [PMID: 12414744]
107. Xuan SY, Li N, Qiang X, Zhou RR, Shi YX, Jiang WJ. Helicobacter infection in hepatocellular carcinoma tissue. World J Gastroenterol 2006; 12: 2335-2340 [PMID: 16688821]